Quarterly report pursuant to Section 13 or 15(d)

SHARE-BASED COMPENSATION - (Details)

v3.24.1.1.u2
SHARE-BASED COMPENSATION - (Details) - USD ($)
1 Months Ended 3 Months Ended
Feb. 29, 2024
Jun. 30, 2023
Feb. 28, 2023
Apr. 30, 2022
Jan. 31, 2022
Jul. 31, 2021
Jun. 30, 2021
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Apr. 30, 2021
Share-based compensation                      
Stock options granted (in shares)               835,000      
Grant exercise price (in dollars per share)               $ 3.15      
Total compensation expense not yet recognized               $ 3,768,883      
Weighted average vesting period               2 years 3 months      
Intrinsic value of stock option                   $ 251,550  
Weighted average grant date fair value               $ 3.96      
June 2021                      
Share-based compensation                      
Share based compensation expense               $ 181,720 $ 181,720    
Common stock shares available (in shares)             807,500        
Grant exercise price (in dollars per share)             $ 6.26        
June 2021 | Employee | Tranche one                      
Share-based compensation                      
Vesting percentage             40.00%        
June 2021 | Employee | Tranche two                      
Share-based compensation                      
Vesting term of options             36 months        
July 2021                      
Share-based compensation                      
Share based compensation expense               490,916 490,916    
Stock options granted (in shares)           1,550,000          
Grant exercise price (in dollars per share)           $ 6.18          
July 2021 | Executive officers | Tranche one                      
Share-based compensation                      
Vesting percentage           25.00%          
July 2021 | Executive officers | Tranche two                      
Share-based compensation                      
Vesting term of options           36 months          
July 2021 | Independent Directors, Consultant                      
Share-based compensation                      
Vesting term of options           36 months          
January 2022                      
Share-based compensation                      
Share based compensation expense               18,950 18,950    
Stock options granted (in shares)         80,000            
Grant exercise price (in dollars per share)         $ 4.44            
January 2022 | Tranche one                      
Share-based compensation                      
Vesting percentage         25.00%            
January 2022 | Tranche two                      
Share-based compensation                      
Vesting term of options         36 months            
April 2022                      
Share-based compensation                      
Share based compensation expense               5,378 5,378    
Stock options granted (in shares)       30,000              
Grant exercise price (in dollars per share)       $ 3.79              
April 2022 | Tranche one                      
Share-based compensation                      
Vesting percentage       25.00%              
April 2022 | Tranche two                      
Share-based compensation                      
Vesting term of options       36 months              
February 2023                      
Share-based compensation                      
Share based compensation expense               109,521 36,508    
Stock options granted (in shares)     467,500                
Grant exercise price (in dollars per share)     $ 3.41                
Vesting term of options     36 months                
June 2023                      
Share-based compensation                      
Share based compensation expense               26,800 $ 0    
Stock options granted (in shares)   50,000                  
Grant exercise price (in dollars per share)   $ 2.75                  
Vesting term of options   1 year                  
February 2024                      
Share-based compensation                      
Share based compensation expense               $ 61,238      
Stock options granted (in shares) 835,000                    
Grant exercise price (in dollars per share) $ 3.15                    
Vesting term of options 36 months                    
2021 Equity Incentive Plan                      
Share-based compensation                      
Common stock shares reserved                     3,454,915
Common stock shares available (in shares)               231,720